Related references
Note: Only part of the references are listed.A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker et al.
LEUKEMIA (2019)
Substratification of patients with newly diagnosed standard-risk multiple myeloma
Moritz Binder et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Plasma Cell Leukemia: Definition, Presentation, and Treatment
Michael Tveden Gundesen et al.
CURRENT ONCOLOGY REPORTS (2019)
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study
Scott R. Goldsmith et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
V. Shah et al.
LEUKEMIA (2018)
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients
Ja Min Byun et al.
CANCER MEDICINE (2018)
Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
M. Binder et al.
BLOOD CANCER JOURNAL (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
High-risk Multiple Myeloma: Definition and Management
Nisha S. Joseph et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
How to Think About Risk in Myeloma
Amrita Krishnan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
B. A. Walker et al.
LEUKEMIA (2014)
IMWG consensus on risk stratification in multiple myeloma
W. J. Chng et al.
LEUKEMIA (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations
Misuk Ji et al.
ANNALS OF HEMATOLOGY (2013)
High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma
Marian Stevens-Kroef et al.
GENES CHROMOSOMES & CANCER (2012)
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
Fiona M. Ross et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Multiple myeloma and the road to personalised medicine
Stephen J. Russell et al.
LANCET ONCOLOGY (2011)
Share Paper
